Biotron's HIV drug candidate reverses impaired immune system
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...Read more
BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...Read more
ResMed wins patent case against China firm in Germany
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2013
Singapore: Australia-based ResMed, a medical device company working on sleep-disordered breathing and respiratory condit...Read more
Major breakthrough in Hep C vaccine development
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...Read more
CMS Medical to distribute EndoBarrier in Brazil
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: GI Dynamics has entered into an agreement with CMS Medical, headquartered in Goiânia, Brazil, to distribut...Read more
Australia court holds 3 AstraZeneca patents invalid
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: In a blow to AstraZeneca, a multinational pharmaceutical company, the Federal Court of Australia has found t...Read more
Research: Cancer epigenetically activates genome
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2013
Singapore: A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows ...Read more
Biodiem develops killer for drug-resistant microbes
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...Read more
Women in life sciences – A peep into the lives of inspirational figures
Australia | Influencers | By BioSpectrum Bureau | 1 Comment | 01 Mar, 2013
We come across several women in the field of biotechnology at the graduation and post-graduation level of education. How...Read more
BSA-CMR Survey: India, China lead in APAC CRO sector
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
New drug to halt flu virus mutation
Australia | News | By Nandita Singh | 0 Comment | 11 Mar, 2013
A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the...Read more
Biotron starts phase II trial for HIV-hepatitis co-infection
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Singapore: Australian drug development company, Biotron, has commenced a landmark phase II human trial of its lead anti...Read more
Biotech nutraceuticals is the way forward
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Food has been used as a pharmaceutical agent to treat diseases since time immemorial and the pharmaceutical use of food ...Read more
First-of-its-kind endogenous fluorescent flower
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2012
Singapore: Adelaide-based company, Bioconst, commenced research on its second generation of fluorescent flowers using DN...Read more
Allied Healthcare's CardioCel trial shows efficacy
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2013
Singapore: Australia-based Allied Healthcare's ongoing phase II extension study for CardioCel, its lead regenerative tis...Read more
CSL to pay $64 mn to settle US antitrust litigation
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
Singapore: Australia biopharmaceutical firm CSL has signed an agreement to settle the US antitrust class action litigati...Read more
Cytori's Celution system gets Aus TGA nod
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Cytori Therapeutics received notice from the Australian Therapeutic Goods Administration (TGA) that its Celut...Read more